No Picture
News

Halozyme to Present Virtually at the 40th Annual J.P. Morgan Health Care Conference

SAN DIEGO: SAN DIEGO, Jan. 4, 2022 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley, president and chief executive officer, will present virtually at the 40th Annual J.P. Morgan Health Care Conference on Monday, January 10, 2022 at 7:30 a.m. PT/ 10:30 a.m. ET. The… Click here to view original post… […]

No Picture
News

Regulus Therapeutics to Present at the H.C. Wainwright Virtual BioConnect Conference

SAN DIEGO: SAN DIEGO, Jan. 4, 2022 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that Jay Hagan, President and Chief Executive Officer of Regulus, will present at the H.C. Wainwright… Click here to view original post… […]

No Picture
News

Evofem Biosciences to Present at H.C. Wainwright BioConnect Conference

SAN DIEGO: SAN DIEGO, Jan. 4, 2022 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that the Company will present and host one-on-one meetings at the H.C. Wainwright BioConnect Virtual Conference being held from January 10 – 13, 2022. Chief Executive Officer Saundra Pelletier will provide an update on… Click here to view original post… […]

No Picture
News

When Mom Talks, Are Infants with ASD Listening?

Researchers at UC San Diego School of Medicine pinpoint the regions of the brain and neural mechanisms responsible for normal or impaired development of a child’s response to baby talk and why infants with autism do not typically respond well. Click here to view original post… […]

No Picture
News

Viking Therapeutics to Present at H.C. Wainwright BioConnect 2022 Conference

SAN DIEGO: SAN DIEGO, Jan. 3, 2022 /PRNewswire/ — Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation as part of the… Click here to view original post… […]

No Picture
News

Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference

SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that the company will participate in a pre-recorded presentation at the H.C. Wainwright BIOCONNECT Virtual Conference…. Click here to view original post… […]

No Picture
Uncategorized

Scientist – Proteogenomics Process Development( NGS, RNA-Seq) – PerkinElmer – San Diego, CA

The incumbent will lead projects to address challenges in manufacturing multiplexed antibody panels and become a key liaison with Bioconjugation, Manufacturing,…From PerkinElmer – Sat, 01 Jan 2022 09:11:44 GMT – View all San Diego, CA […]

No Picture
Uncategorized

Associate Scientist (or Senior Research Associate) – Flow Cytometry – PerkinElmer – San Diego, CA

BioLegend develops world-class, cutting-edge antibodies and reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, CA.From PerkinElmer – Sat, 01 Jan 2022 09:11:44 GMT – View all San Diego, CA jobsClick here […]